Even if not quite significant, treatment of the mice using Aviscumine monotherapy prolonged the median survival compared to control treated mice (62 d in the Aviscumine group versus 46.5 d in the control group, p=0.0803) and was even superior to tumor irradiation (62 d in the Aviscumine group versus 57 d in the irradiated group, p=0.1222).
← all excerpts
Mistletoe-Based Drugs Work in Synergy with Radio-Chemotherapy in the Treatment of Glioma <i>In Vitro</i> and <i>In Vivo</i> in Glioblastoma Bearing Mice.
1
—
—